Equity Overview
Price & Market Data
Price: $0.0₃65
Daily Change: +$0.0₄5 / 7.69%
Range: $0.0₃6 - $0.0₃7
Market Cap: $3,219,006
Volume: 3,447,739
Performance Metrics
1 Week: -14.29%
1 Month: -14.29%
3 Months: -33.33%
6 Months: -62.50%
1 Year: -85.71%
YTD: -25.00%
Details
Enzolytics Inc., a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. The company has clinically tested anti-HIV therapeutics. In addition, the company's proprietary cell line produces human monoclonal antibodies that target and neutralizes the HIV virus. Enzolytics Inc. is based in Plano, Texas.